LPAR6 and ovarian cancer: Furthermore, the determination of patient cohorts from PrognoScan database and Kaplan–Meier Plotter demonstrated a high mRNA expression level of LPAR6 is correlated with better prognosis in breast, lung, bladder, colorectal, eye and ovarian cancer (Figure 2).